Mei Ri Jing Ji Xin Wen·2025-06-10 23:07Group 1 - Hong Kong's Chief Executive John Lee announced that the 2025 Policy Address will be published in September, highlighting efforts to change government culture and accelerate government work [1] - Hong Kong's GDP is estimated to grow by 2% to 3% this year, indicating positive economic expansion despite challenges in certain industries [1] Group 2 - Six cities in Guangdong, including Shenzhen and Zhuhai, signed a cooperation agreement to promote the "same city" experience for housing provident fund services, enhancing convenience for residents [2] - The agreement aims to facilitate seamless services, mutual recognition of loans, and information sharing across regions [2][3] Group 3 - The world's first PB2 drug for treating H1N1 influenza, developed by Chinese Academy of Engineering academician Zhong Nanshan, has been approved for market release, marking a significant advancement in domestic pharmaceutical capabilities [4] - Previously, over 80% of influenza medication sales in China were dominated by imported drugs, highlighting the importance of this new domestic drug [4] Group 4 - The construction of the third unit of the Guangdong Taipingling Nuclear Power Plant has commenced, with a total investment exceeding 120 billion yuan for the entire project [5] - Once completed, the project will have a total installed capacity of over 7.2 million kilowatts and is expected to provide approximately 53 billion kilowatt-hours of clean energy annually [5][6] Group 5 - The Shenzhen Component Index closed at 10,162.18 points, down 0.86% [7] - Notable gainers included Huaye Fragrance, Zhongke Magnetic, and Saiseng Pharmaceutical, each rising by 20% [8] - Significant decliners included Jieqiang Equipment, Erkang Biochemical, and Wanbangde, with declines of 14.76%, 10.32%, and 10.03% respectively [8]